Virtus Fund Advisers’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Virtus Fund Advisers’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$1.2M	Buy	+23,337	New	+$1.68M	0.01%	276

Other funds holding ONCE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Virtus Fund Advisers's ONCE Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2017: 23,337 shares worth $1.2M. The stake represents 0.01% of the portfolio and ranks #276 among its holdings.

160 funds tracked by Wall St. Rank hold ONCE as of Q4 2017.

Virtus Fund Advisers held 23,337 shares of Spark Therapeutics, Inc. Common Stock worth $1.2M as of Q4 2017.
Spark Therapeutics, Inc. Common Stock was a new Virtus Fund Advisers position in Q4 2017.
Spark Therapeutics, Inc. Common Stock made up 0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #276 holding.
160 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.